Remarkably, subsequent studies found that APOL1 high risk genotypes are associated with 29-fold increased risk of HIVAN in African Americans and an 89-fold increase risk in South Africans and HIV-positive patients are at 50% lifetime risk of developing HIVAN without antiretroviral treatment (85, 86). This evidence concerns the gene APOL1 and HIV-associated nephropathy.